The use of mice as animal model for testing acute toxicity (LD-50) of toxic shock syndrome toxin;Utilização de camundongos como modelo animal para a verificação da toxicidade aguda da toxina-1 da síndrome do choque tóxico

Arquivo Brasileiro de Medicina Veterinaria e Zootecnia

Volumn 61, Issue 1, 2009, Pages 170-173

  Dias, R S ^a,c   Carmo, L S ^a,b   Heneine, L G D ^a,c   Rocha, P H ^a   Barbosa, C F ^a   Rodrigues, R J ^a   Linardi, V R ^b  

^a FUNDAÇÃO EZEQUIEL DIAS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Centro Universitario Metodista Izabela Hendrix   (Brazil)

Author keywords

Acute toxicity (LD 50); Mice; Staphylococcus; TSST 1

Indexed keywords

ANIMALIA; ESCHERICHIA COLI; MUS; STAPHYLOCOCCUS;

EID: 67249155238     PISSN: 01020935     EISSN: 16784162     Source Type: Journal    
DOI: 10.1590/S0102-09352009000100024     Document Type: Article

References (14)

1. Bavari, S.; Ulrich, R.G.; Le Claire, R.D. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens. J. Infect. Dis., v.180, p.1365-1369, 1999.
2. Blomster-Hautamaa, D.A.; Kreiswirth, B.N.; Novick, R.P. et al. Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoeletric focusing. Biochemistry, v.9, p.25-54, 1986.
3. Bulanda, M.; Zaleska, M.; Mandel, L. et al. Toxicity of staphylococcal toxic shock syndrome toxin 1 goes germ free and conventional piglets. Rev. Infect. Dis., v.11, suppl.1, p. s:248-253, 1989.
4. Carmo, L.S. Produção e purificação em grande escala das enterotoxinas estafilocócicas SEA, SEB, SEC2, SED e TSST-1 para uso em ensaios imuno-enzimáticos. 2001. 254f. Tese (Doutorado) - Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte.
5. 2 in toxic shock syndrome. J. Exp. Med., v.172, p.981-984, 1990.
6. Finney, D.J. Probits analysis. 3.ed. Cambridge: University Press, 1971.
7. Henne, E.; Campbell, W.H.; Carlson, E. Toxic shock syndrome toxin 1 enhances synthesis of endotoxin - induced tumor necrosis factor in mice. Infect. Immun., v.59, p.2929-2933, 1991.
8. Jones, T.O.; Wieneke, A.A. Staphylococcal toxic shock syndrome. Vet. Rec., v.25, p.34-45, 1986.
9. Matsunaga, T.; Kamata, S.; Kikiichi, N. Characteristics of Staphylococcus aureus isolated from peracute, acute, and chronic bovine mastitis. J. Med. Sci., v.55 p.297-300, 1993.
10. Parsonnet, J.; Kasper, D.L. Toxic shock syndrome: clinical developments and new biology. In: Wilson, J.D.; Braunwald, E.; Isselbacher, K.J. et al. (Eds). Harrison's principles of internal medicine. 12.ed. New York: Mc Graw-Hill, 1992.
11. Reeves, M.W.; Arko, R.J.; Chanlder, F.W. et al. Affinity purification of staphylococcal toxic shock syndrome toxin-1 and its pathologic effect in rabbits. Infect. Immun., v.51, p.431-439, 1986.
12. Stiles, B.G.; Krakauer, T.; Bonventre, P.F. Biological activity of toxic shock syndrome toxin 1 and a site -directed mutant, H135A, in a lipopolysaccharide -potentiated mouse lethality model. Infect. Immun., p.1229-1234, 1995.
13. Sugyama, H.; Mckissic, E.M.; Bergdoll, M.S. et al. Enhancement of bacterial endotoxin lethality by staphylococcal enterotoxin. J. Infect. Dis., v.114, p.111-118, 1964.
14. Uchiyama, T.; Tadakuma, T.; Imanishi, K. et al. Activation of murine T cells by toxic shock syndrome toxin-1. J. Immunol., v.143, p.3175-3182, 1989.